Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52.
Saved in:
| Title: | Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52. |
|---|---|
| Authors: | Lee JS; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea., Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Miyagi, Japan., Kang JH; Department of Medical Oncology, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, South Korea., Kim HR; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, Severance Hospital, Yonsei University Health System, Seoul, South Korea., Inui N; Department of Pulmonary Medicine, Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan., Hida T; Department of Thoracic Oncology, Aichi Cancer Center, Nagoya, Aichi, Japan., Lee KH; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, South Korea., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Tanaka H; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan., Yang CT; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishio M; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Tamura T; Thoracic Center, St. Luke's International Hospital, Tokyo, Japan., Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama, Wakayama, Japan., Yu CJ; Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu City, Hsinchu County, Taiwan., Akamatsu H; Internal Medicine III, Wakayama Medical University, Wakayama, Wakayama, Japan., Takahashi S; Oncology Clinical Development Planning 1, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan. |
| Source: | Cancer science [Cancer Sci] 2026 Apr; Vol. 117 (4), pp. 1124-1135. Date of Electronic Publication: 2026 Jan 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1349-7006 |
|---|---|
| DOI: | 10.1111/cas.70330 |
